Phathom Pharmaceuticals (PHAT) Other Non Operating Income (2019 - 2026)
Phathom Pharmaceuticals (PHAT) reported Other Non Operating Income of -$831000.0 for Q1 2026, down 3677.27% year-over-year from $23230.0 in Q1 2025, and down 16520.0% quarter-over-quarter from -$5000.0 in Q4 2025.
Phathom Pharmaceuticals (PHAT) Other Non Operating Income (2019 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 8 years of Other Non Operating Income data on file, last reported at -$831000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$831000.0, down 3677.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$998000.0 (down 7776.92% YoY), and the FY2025 annual result was -$190000.0, down 2275.0% from the prior year.
- Other Non Operating Income slipped to -$831000.0 in Q1 2026 per PHAT's latest filing, from -$5000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $49000.0 in Q4 2024 and troughed at -$831000.0 in Q1 2026.
- A 5-year average of -$78000.0 and a median of -$8000.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2026: Other Non Operating Income surged 450.0% in 2024, then plunged 3677.27% in 2026.
- A 5-year view of Other Non Operating Income shows it stood at -$90000.0 in 2022, then soared by 84.44% to -$14000.0 in 2023, then surged by 450.0% to $49000.0 in 2024, then slumped by 110.2% to -$5000.0 in 2025, then plunged by 16520.0% to -$831000.0 in 2026.
- Business Quant data shows PHAT's Other Non Operating Income at -$831000.0 in Q1 2026, -$5000.0 in Q4 2025, and -$7000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Phathom Pharmaceuticals | 895.99 Mn | 712.23 Mn | 46.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -831,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Jun 30, 2025 | -155,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | -197,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | -90,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Mar 31, 2022 | -7,000.00 |
| Dec 31, 2021 | -17,000.00 |
| Sep 30, 2021 | -2.05 Mn |
| Jun 30, 2021 | 10,000.00 |